Market Overview

European PDX Models Market Review 2016-2018 and Forecast to 2025: Analysis by Type, Tumour Type, Application, End-User and Geography - ResearchAndMarkets.com

Share:

The "Europe
PDX Models Market - Companies Profiles, Size, Share, Growth, Trends and
Forecast to 2025"
report has been added to ResearchAndMarkets.com's
offering.

Europe PDX models market was valued at USD 26.95 million in 2017 and
growing at a lucrative rate of CAGR in the assessment period.

The new market report contains data for historic years 2016, the base
year of calculation is 2017 and the forecast period is 2018 to 2025.

The Europe PDX models market is segmented based on type into two notable
segments; mice models and rat models. In 2018, mice models segment is
valued to rule with the highest market share 2025.

The Europe PDX models market is segmented in tumour type categories into
six notable segments; respiratory tumour models, urological tumour
models, gastrointestinal tumour models, hematological tumour models,
gynecological tumour models and others. In 2018, respiratory tumour
models segment is valued to rule with the highest market shares by 2025,
rising at the highest CAGR.

The Europe PDX models market is segmented in application into
preclinical drug development and oncology research and biomarker
analysis. In 2018, preclinical drug development and oncology research
segment is valued to rule with highest market shares and rising at the
highest CAGR.

The Europe PDX models market is segmented in end user into contract
research organization (CRO), academic and research institutions and
pharmaceutical and biotechnology companies. In 2018, contract research
organization (CRO) segment is valued to rule with highest market shares
and rising at the highest CAGR.

Market Dynamics

Drivers

  • Rising Number of Pharmaceutical R&D Activities in Cancer Research
  • PDX Models Offer Advantages as Compared With the Classic Approach
  • Rising Need for Personalized Medicine
  • Increasing Support for Cancer Research Activities from Government and
    Non-Government Organization

Restraints

  • High Cost of PDX Models
  • Strict Regulation With Respect to the Utilization of Animal Models in
    Cancer Research

Opportunities

  • Increasing Demand for Humanized PDX Models

Challenges

  • Limitations of PDX Models

Key Topics Covered

1 Introduction

2 Market Segmentation

3 Market Overview

4 Executive Summary

5 Premium Insights

6 Europe PDX Models Market, by Type

7 Europe PDX Models Market, by Tumour Type

8 Europe PDX Models Market, by Application

9 Europe PDX Models Market, by End-User

10 Europe PDX Models Market, by Geography

11 Europe PDX Models Market, Company Landscape

12 Company Profiles

  • Crown Bioscience Inc.
  • The Jackson Laboratory
  • Champion Oncology Inc.
  • Charles River
  • Oncodesign
  • Wuxi AppTec
  • Horizon Discovery Group PLC
  • Pharmatest Services
  • Hera Biolabs
  • EPO Berlin-Buch GmbH
  • Xentech
  • Urolead
  • Creative Animodel
  • EuroPDX
  • MI Bioresearch Inc.
  • Aragen Bioscience

For more information about this report visit https://www.researchandmarkets.com/research/xf2f6w/european_pdx?w=4

View Comments and Join the Discussion!